Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06810349

Predicting Tumor Origin Based on Deep Learning of Lymph Node Puncture Cytology

In this study, the investigators aimed to construct a deep learning diagnostic model that uses cytological images to predict primary unknown tumor origins in patients with tumors combined with lymph node metastases. After the model is constructed, the model will be validated by a large-scale test set to test the model performance. The investigators also propose to compare the performance of the constructed model in diagnosing cytology smears compared to human pathologists.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

West China Hospital of Sichuan University

Chengdu, Sichuan, 610041, China

Location status: Recruiting

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • From West China Hospital of Sichuan University (October 1, 2008-August 31, 2024) with corresponding clinical data, including age, sex, specimen puncture site, pathologic diagnosis, pathologic type, whether immunocytochemistry was added, clinical diagnosis, lesion site, co-morbidities, history of malignancy, treatment modality, occurrence of postoperative complications, total number of days of hospitalization postoperatively, and survival time;
  • From the Department of Pathology of the First Affiliated Hospital of Zhengzhou University, the Sichuan Provincial Cancer Hospital, and the Cancer Hospital of the Chinese Academy of Medical Sciences (January 1, 2020-August 31, 2024) with corresponding clinical data, including age, sex, specimen puncture site, pathologic diagnosis, pathologic type, whether immunocytochemistry was added, clinical diagnosis, lesion site, co-morbidities, history of malignancy, treatment modality, occurrence of postoperative complications, total number of days of hospitalization postoperatively, and survival time.

Exclusion criteria

  • Images lacking any supporting clinical or pathologic evidence to support a primary origin and its corresponding clinical information;
  • Blank, poorly focused, and low-quality images containing severe artifacts and their corresponding clinical information.

Treatment and study plan

Primary outcomes

  1. Model performance metrics

    Time frame: 1 year

    Model performance was evaluated by Positive Predictive Value (PPV), Negative Predictive Value (NPV), Accuracy, Sensitivity and Specificity.

Study contacts

Contact information is provided by the study sponsor or research team.

Jianyong Lei

CONTACT

[email protected]

02885423822

Sponsors and collaborators

Lead sponsor

West China Hospital

Other

Registry information

Official study title

A Multicenter Study on Predicting Tumor Origin Based on Deep Learning of Lymph Node Puncture Cytology

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Feb 5, 2025
Registry last updated
Feb 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.